Codrin I. Lungu
Affiliations: | National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States |
Area:
Movement DisordersGoogle:
"Codrin Lungu"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Heiss JD, Ray-Chaudhury A, Kleiner DE, et al. (2024) Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
Rocco MT, Akhter AS, Ehrlich DJ, et al. (2023) Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Lungu C, Nmashie A, George MC, et al. (2022) Comparison of Ultrasound and Electrical Stimulation Guidance for Onabotulinum Toxin-A Injections: A Randomized Crossover Study. Movement Disorders Clinical Practice. 9: 1055-1061 |
Rocco MT, Akhter AS, Ehrlich DJ, et al. (2022) Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of patients with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Hattori T, Reynolds R, Wiggs E, et al. (2022) Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease. Neuroimage. Clinical. 35: 103100 |
Vanegas-Arroyave N, Chen DF, Lauro PM, et al. (2022) Where Do Parkinson's Disease Patients Look while Walking? Movement Disorders : Official Journal of the Movement Disorder Society |
Kilic-Berkmen G, Wright LJ, Perlmutter JS, et al. (2021) The Dystonia Coalition: A Multicenter Network for Clinical and Translational Studies. Frontiers in Neurology. 12: 660909 |
Barker RA, Bjorklund A, Gash DM, et al. (2020) GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease |
Lungu C, Ozelius L, Standaert D, et al. (2020) Defining research priorities in dystonia. Neurology |
Staffaroni AM, Bajorek L, Casaletto KB, et al. (2020) Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 11-21 |